Bram Van Den Eeckhout

3PUBLICATIONS
18CO-AUTHORS
Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 03, 2024
In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA).

Marie-Angélique De Scheerder, Sophie Degroote, Mareva Delporte

|Nov 13, 2021
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication.

Bram Van Den Eeckhout, Leander Huyghe, Sandra Van Lint

|Jul 28, 2020
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.

Bram Van Den Eeckhout, Lien Van Hoecke, Elianne Burg

Pageof 1